Merck's recent decline is due to reduced profit guidance and FDA decisions, but shares are at a support level. Read why I ...

TiumBio begins patient dosing in phase 2 trial of oral immuno-oncology drug TU2218: Republic of Korea Monday, October 7, 2024, 12:00 Hrs [IST] TiumBio Co., Ltd., a clinical-stage ...

One in eight, or 13%, of women in the United States will develop breast cancer. The five-year survival rate for breast cancer ...

We recently compiled a list of the 7 Best Under The Radar Stocks to Buy According to Analysts. In this article, we are going ...

Malignant cells can then spread to neighboring tissues and lymph nodes ... A stage 0 diagnosis (also called “ductal carcinoma in situ”) indicates the presence of non-invasive cancer cells in the milk ...